Successfully tested in mice, targeted drug and gene therapies might one day benefit patients with a deadly lung disease, new U-M research finds.

Michigan Medicine researchers sought to find out if they can anticipate who will be affected by psychiatric morbidity after surviving acute respiratory distress syndrome.